TABLE 2.
Results of liquid mating conjugation of S. sonnei isolatesa
Isolate no.b | Resistance profilec | Transconjugant resistance profilec | Selective agard | Size (kb) of transconjugant plasmid(s) |
---|---|---|---|---|
3331Ab | ASSu | ASSuNa | A + Na | 2,12, and 48 |
3331Ab | ASSu | ANa | A + Na | 48 |
3599Ab | A | ANa | A + Na | 11 and 45 |
CK2Bi | ASSuTTm | ASuTNa | A + Na | 5 and 60 |
3219Ab | ASuTm | ANa | A + Na | 33 |
3219Ab | ASuTm | ASuTmNa | Tm + Na | 47 |
D3B3k | SSuTTm | SSuTNa | T + Na | 60 |
No transconjugants were obtained with isolate 3331, CK2, or D3 when streptomycin (30 mg/ml) and nalidixic acid (30 μg/ml) were used. No transconjugants were obtained with isolate CK2 or D3 when Mueller-Hinton agar with nalidixic acid (30 μg/ml) and trimethoprim (5 μg/ml) were used.
Superscript letters indicate the PFGE type (upper case letters) and plasmid profile pattern (lowercase letters) for each strain.
The resistance profiles are represented by the abbreviations for the antimicrobial agents to which the isolate tested was resistant: A, ampicillin; S, streptomycin; Su, sulfonamides; T, tetracycline; Tm, trimethoprim.
Isolates were selected on Tryptone soya agar with nalidixic acid (30 μg/ml) and ampicillin (100 μg/ml) (A + Na) or tetracycline (20 μg/ml) (T + Na) or Mueller-Hinton agar with nalidixic acid (30 μg/ml) and trimethoprim (5 μg/ml) (Tm + Na).